The hemodialysis vascular grafts market is set to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 representing balanced growth at a compounded annual growth rate (CAGR) of 4.3% during the forecast period from 2018 to 2026. Atrial fibrillation is the most common type of cardiac arrhythmia diagnosed globally. According to the research findings brought forward by World Health Organization (WHO), the number of end stage renal disease patients worldwide receiving dialysis will be approximately 5.24 million by 2030. The common causes associated with morbidity during hemodialysis are infection, hemorrhage and vascular grafts rejection. Synthetic materials are being made with a blend of polymers to achieve the desired materials strength, adhesion, durability and pliability. Bioengineered materials will be the latest trendsetter due to advantages associated with it such as negligible graft rejection and excellent biocompatibility.

"Excellent adhesion, native fistula pliability and reimbursement scenario drive the polytetrafluoroethylene raw material market growth"

Polytetrafluoroethylene is leading the raw material segment for hemodialysis vascular grafts market. The primary features which are responsible for the dominance of polytetrafluoroethylene as a vascular graft are outstanding adhesion properties, native fistula pliability and reimbursement scenario. High dielectic strength and low coeeficent of friction ensures smooth and painless hemodialysis procedure in patients suffering with chronic kidney disease.  Polyurethane holds the second largest market owing to positive attributes such as its material strength and ability to provide thinner inner wall as a vascular graft thereby providing larger inner luminal diameter to provide excellent blood flow during hemodialysis procedure. Biological raw material will be the fastest growing segment during the forecast period owing to less infection rate, low hemorrhage and excellent biocompatibility. They are made from human saphenous veins and other bioengineered material. "Increasing geriatric population suffering with chronic kidney disease and increased healthcare expenditure drive the market growth in North America"

North America is presently holding 36% share in the regional segment for hemodialysis vascular grafts market. As per the research study conducted by Center for Disease Control and Prevention (CDC) in 2016, approximately 4.9 million United States citizens were reported to be diagnosed with kidney disease. The drivers that promote the market growth in North America region are increasing healthcare expenditure and rising geriatric population suffering with chronic kidney disease. Existence of major players such as C.R.Bard, Inc., Terumo Medical Corporation and W.L.Gore & Associates etc. further propel the market growth in North America region. Europe holds the second largest market with 28% share owing to the supportive regulatory environment provided by European Medical Agency (EMA) and increasing demand for hemodialysis in comparison to peritoneal dialysis. Asia Pacific represents 20% market share and is to register excellent during in the near future on account of increasing prevalence of renal disorders and proactive government policies to counteract kidney complications.

Pharmaceutical companies manufacturing hemodialysis vascular grafts are C.R.Bard, Inc., CryoLife, Inc., Getinge AB., InnAVasc Medical, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Proteon Therapeutics, Inc., Terumo Medical Corporation, Vascular Genesis and W.L.Gore Associates.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Hemodialysis Vascular Grafts market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Hemodialysis Vascular Grafts market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Hemodialysis Vascular Grafts market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Hemodialysis Vascular Grafts market?
• Which is the largest regional market for Hemodialysis Vascular Grafts market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Hemodialysis Vascular Grafts market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Hemodialysis Vascular Grafts market worldwide?